Discovery of Novel Drugs for Promising Targets

被引:15
|
作者
Martell, Robert E. [1 ,2 ]
Brooks, David G. [1 ]
Wang, Yan [1 ]
Wilcoxen, Keith [1 ]
机构
[1] TESARO Inc, Waltham, MA USA
[2] Tufts Med Ctr, Boston, MA USA
关键词
cancer; drug discovery; GENOTYPE-CORRELATED SENSITIVITY; SYNTHETIC LETHALITY; KINASE INHIBITORS; HIGHLY POTENT; SEMANTIC WEB; CANCER; BINDING; IDENTIFICATION; BIOLOGY; MODELS;
D O I
10.1016/j.clinthera.2013.08.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Once a promising drug target is identified, the steps to actually discover and optimize a drug are diverse and challenging. Objective: The goal of this study was to provide a road map to navigate drug discovery. Methods: Review general steps for drug discovery and provide illustrating references. Results: A number of approaches are available to enhance and accelerate target identification and validation. Consideration of a variety of potential mechanisms of action of potential drugs can guide discovery efforts. The hit to lead stage may involve techniques such as high-throughput screening, fragment-based screening, and structure-based design, with informatics playing an ever-increasing role. Biologically relevant screening models are discussed, including cell lines, 3-dimensional culture, and in vivo screening. The process of enabling human studies for an investigational drug is also discussed. Conclusions: Drug discovery is a complex process that has significantly evolved in recent years. (C) 2013 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:1271 / 1281
页数:11
相关论文
共 50 条
  • [1] Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets
    Chen, Yadan
    Ma, Haiming
    Zhu, Dasheng
    Zhao, Guowei
    Wang, Lili
    Fu, Xiujuan
    Chen, Wei
    PPAR RESEARCH, 2017, 2017
  • [2] Discovery and Exploitation of Novel Targets by Approved Drugs
    Dirix, Luc
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (08) : 720 - 721
  • [3] Rho GTPases: Promising cellular targets for novel anticancer drugs
    Fritz, G
    Kaina, B
    CURRENT CANCER DRUG TARGETS, 2006, 6 (01) : 1 - 14
  • [4] Discovery of novel targets of quinoline drugs in the human purine binding proteome
    Graves, PR
    Kwiek, JJ
    Fadden, P
    Ray, R
    Hardeman, K
    Coley, AM
    Foley, M
    Haystead, TAJ
    MOLECULAR PHARMACOLOGY, 2002, 62 (06) : 1364 - 1372
  • [5] Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets
    Donald M. Coen
    Priscilla A. Schaffer
    Nature Reviews Drug Discovery, 2003, 2 : 278 - 288
  • [6] Antiherpesvirus drugs: A promising spectrum of new drugs and drug targets
    Coen, DM
    Schaffer, PA
    NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (04) : 278 - 288
  • [7] New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
    Ni, Xiayun
    Zhang, Lei
    Feng, Xiaojun
    Tang, Liqin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Nuclear proteins: Promising targets for cancer drugs
    Yao, YL
    Yang, WM
    CURRENT CANCER DRUG TARGETS, 2005, 5 (08) : 595 - 610
  • [9] Promising neuroimmune targets and drugs for CNS diseases
    Madukwe, Jerry
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (08) : 609 - 610
  • [10] Promising Targets and Drugs in Development for Colorectal Cancer
    Thompson, Chris
    Leong, Stephen
    Messersmith, Wells
    SEMINARS IN ONCOLOGY, 2011, 38 (04) : 588 - 597